The Asahi Glass Foundation Announces the Results of the 32nd Annual “Questionnaire on Environmental Problems and the Survival of Humankind”
The Asahi Glass Foundation (Chairman: Takuya Shimamura) has conducted an annual survey with environmental experts from around the world since 1992. This year, we sent the questionnaire to 202 countries around the world, and received responses from 1,805 people in 130 countries. Below are the main points from this year’s questionnaire results. Further details are available in the report of the “32nd Annual Questionnaire on Environmental Problems and the Survival of Humankind,” or online at the Foundation’s web site (https://www.af-info.or.jp/en/), starting at 11 a.m. JST on September 6, 2023.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905353048/en/
Change in the Time on the Environmental Doomsday Clock Since 1992 (Graphic: Business Wire)
- The time on the Environmental Doomsday Clock has turned back for three consecutive years since 2021, striking 9:31 in 2023.
- Looking at the time on the Clock around the world, the Clock went back more than 10 minutes compared to last year in South America, Western Europe, and the Middle East; but it moved forward more than 20 minutes in Mexico, Central America & the Caribbean, and Eastern Europe & former Soviet Union.
- "Climate Change" has been the top environmental issue since 2011 that the respondents worldwide have had on their minds in determining the time on the Clock.
- With regard to transitioning to a decarbonized society, the results showed an equal lack of progress in “Policies and Legal System” and “Social Infrastructure (Funds, Human Resources, Technologies, and Facilities)” compared with “Public Awareness.”
- Regarding the world’s problems, “13. Climate Action” was the most selected as the goal that respondents are most concerned about, followed by “1. No Poverty,” and “16. Peace, Justice and Strong Institutions.”
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
THE ASAHI GLASS FOUNDATION
Toshihiro Tanuma, PhD
TEL: +81 3 5275 0620
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ARMA Instruments Launch Zero Trust G1 Mark II Secure Messaging Communication Device3.10.2023 05:00:00 CEST | Press release
The Russian invasion of Ukraine has ignited an arms race in the theater of cyber warfare. Zero trust is the operative term for military, defense sectors, and governments across the globe. U.S. intelligence agencies and international partners recently published a report warning of the new Russian malware program Sandworm, likely targeting Ukrainian interests in its ongoing war, and U.S. defense agencies set a deadline of 2027 for implementation of zero trust cybersecurity environments [FedTech, August 2023]. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231002887540/en/ Switzerland-based ARMA Instruments AG announces the launch of their ARMA G1 Mark II Secure Messaging Device. Developed with zero trust principles, the device is a closed mobile system for person-to-person messaging at the highest security levels to counter advanced adversary attacks. The device will be beneficial for NGOs, defense agencies, cybersecurity oper
SLB Launches Carbon Storage Screening and Ranking Solution3.10.2023 04:00:00 CEST | Press release
SLB (NYSE: SLB) today launched its carbon storage screening and ranking solution that increases confidence in site selection decisions based on scientific analysis of the long-term integrity and economic potential of an asset. The solution helps customers avoid suboptimal storage sites with risk factors that can waste valuable time and resources as well as decrease the probability of a carbon capture, utilization and storage (CCUS) project reaching final investment decision (FID). “CCUS is one of the most immediate opportunities to reduce emissions, but it must scale up by 100–200 times in less than three decades to have the expected impact on global net zero ambitions,” said Frederik Majkut, senior vice president of Carbon Solutions for SLB’s New Energy business. “Ensuring that a storage site is both safer and economical is crucial for the speed, scale and investment needed to meaningfully drive CCUS growth for a low carbon energy ecosystem.” The screening and ranking solution uses bo
Takeda Provides Update on EXKIVITY ® (mobocertinib)2.10.2023 22:30:00 CEST | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that, following discussions with the U.S. Food and Drug Administration (FDA), it will be working with the FDA towards a voluntary withdrawal of EXKIVITY® (mobocertinib) in the U.S. for adult patients with epidermal growth factor receptor (EGFR) Exon20 insertion mutation-positive (insertion+) locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on or after platinum-based chemotherapy. Takeda intends to similarly initiate voluntary withdrawal globally where EXKIVITY is approved and is working with regulators in other countries where it is currently available on next steps. This decision was based on the outcome of the Phase 3 EXCLAIM-2 confirmatory trial, which did not meet its primary endpoint and thus did not fulfill the confirmatory data requirements of the Accelerated Approval granted by the U.S. FDA nor the conditional marketing approvals granted in other countries. The EXCLAIM-2 trial was a Phase 3
Galderma announces progress with RelabotulinumtoxinA regulatory submissions2.10.2023 22:27:00 CEST | Press release
Galderma, the emerging pure-play dermatology category leader, announced today updates related to the regulatory progress of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA (QM-1114) to the U.S. Food and Drug Administration (“FDA”). The FDA has issued a Complete Response Letter (“CRL”) to Galderma related to its BLA for RelabotulinumtoxinA for the treatment of moderate-to-severe glabellar lines (frown lines) associated with corrugator and/or procerus muscle activity in adult patients as well as moderate-to-severe lateral canthal lines (crow’s feet) associated with orbicularis oculi muscle activity in adult patients. The CRL points out certain deficiencies isolated to items related to Chemistry, Manufacturing, and Controls (“CMC”) processes. All other aspects of the BLA, including safety and efficacy related parts, did not solicit deficiencies to be addressed. Galderma has already identified changes to the manufacturing process to address feedback. It will also
Visa Launches $100 million Generative AI Ventures Initiative2.10.2023 22:05:00 CEST | Press release
Visa (NYSE: V), a global leader in payments, today announced a new $100 million generative AI ventures initiative to invest in the next generation of companies focused on developing generative AI technologies and applications that will impact the future of commerce and payments. As a pioneer of AI use in payments since 1993, Visa considers this initiative an extension of Visa’s leadership in using AI to drive innovation in payments, create value for partners and clients, and enable and empower global commerce. Generative AI is an emerging subset of AI that is built on Large Language Models (LLMs) to develop artificial general intelligence capable of generating text, images or other content from large sets of existing data when given prompts. “While much of generative AI so far has been focused on tasks and content creation, this technology will soon not only reshape how we live and work, but it will also meaningfully change commerce in ways we need to understand,” said Jack Forestell,